Sunshine Insurance Group Company Limited is a comprehensive insurance provider based in Beijing, China. The company operates through three main segments: life insurance, property and casualty insurance, and other services. Its life insurance segment, primarily branded as Sunshine Life, offers a diverse array of life insurance products. The property and casualty segment, represented by Sunshine P&C and Sunshine Surety, provides a wide range of insurance solutions addressing various property and casualty needs. Additionally, the company engages in corporate management and asset management services through its other businesses segment. A significant portion of Sunshine Insurance Group's revenue is generated from its property and casualty insurance offerings, reflecting its strong position within this sector.
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.
Data Grand
Series C in 2022
Data Grand specializes in text processing technology and intelligent office robot services, offering a range of solutions aimed at enhancing business efficiency across various industries. Their services include a text mining engine, intelligent recommendation systems, knowledge graphs, smart document reviews, and advanced search systems. Additionally, Data Grand provides tools for customer opinion insights, optical character recognition, and robotic process automation. By employing cutting-edge technologies such as natural language understanding and generation, the company enables users to efficiently extract, review, and search information from extensive databases. This focus on intelligent software systems helps enterprises improve their data mining capabilities while ensuring compliance and safety.
Grit Science
Series A in 2022
Grit Science is a biotechnology company specializing in gene therapeutics, particularly focusing on the research and development of liver-related genes. The firm is dedicated to creating medical products and genetic treatments that address clinical needs and enhance human health. Through its innovative approach to biopharmaceutical technology, Grit Science aims to contribute significantly to the field of medicine by developing solutions that improve patient outcomes.
ChangXin Memory Technologies
Venture Round in 2022
ChangXin Memory Technologies focuses on the development and manufacture of dynamic random-access memory (DRAM) semiconductor products. The company specializes in integrated circuits designed for data memory and related functions, emphasizing low-power data storage solutions. Its activities encompass research and development, design, production, and sales of these integrated circuits, catering to various industry users.
Zaihui
Series D in 2022
Zaihui is a Chinese company founded in 2015 that specializes in providing a SaaS-based data-driven marketing automation solution tailored for local businesses. The company offers a comprehensive platform that includes member management, customer relationship management, and customized marketing strategies supported by big data. Zaihui's services enable local merchants, particularly in the restaurant sector, to enhance operational efficiency through features such as QR code ordering, online payment, and loyalty programs. The platform facilitates intelligent precision marketing, brand packaging, and various promotional activities, empowering small and medium-sized enterprises to establish their unique branding and improve customer engagement.
ImmuneOnco
Series C in 2022
ImmuneOnco Biopharma, established in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an early-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company aims to combat cancer by reversing immune suppression caused by cancer cells and actively targeting their eradication. ImmuneOnco employs a systematic approach to leverage both the innate and adaptive immune systems, which positions it among the few biotechnology firms globally pursuing this strategy. The company has developed a diverse pipeline of 14 drug candidates, with eight currently undergoing clinical programs. This extensive portfolio underscores ImmuneOnco's deep understanding of cancer biology and immunology, as well as its capability to translate scientific research into viable therapeutic options.
XuanZhu Pharma
Series B in 2021
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.
Neurophth Therapeutics
Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
GeekBang
Series B in 2021
GeekBang Technology Ltd., headquartered in Beijing, China, operates a global online learning platform for digital talents. It offers immersive, in-depth learning experiences through live broadcasts, communities, and tribes, covering a wide range of IT subjects. The company also provides media, conference, training, consulting, and social services, fostering communities and facilitating knowledge transfer among technology professionals. Contact details can be found on their official website.
Lepu Bio
Series B in 2020
Lepu Biotechnology Co., Ltd. is a Chinese biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform dedicated to target discovery, drug preparation, development, and manufacturing. The company focuses on creating drug candidates that include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). Lepu Bio's core products are currently in clinical stages I to III, demonstrating its commitment to advancing cancer treatment through innovative biopharmaceutical solutions.
MabPlex
Series B in 2020
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.
Norson Biotechnology
Series B in 2020
Norson Biotechnology produces edible probiotic powder, probiotic solid beverages, fermented lactic acid bacteria beverages, and other products.
Huisuanzhang
Series C in 2020
Huisuanzhang is a financial services platform that caters to small and medium-sized enterprises (SMEs) in China, offering a range of services including accounting, business registration, tax audits, and trademark registration. Established in April 2015, the company has expanded its reach with seven branches across major cities such as Beijing, Shanghai, and Guangzhou, and its service network now spans over 200 cities through more than 300 regional agencies, serving over 230,000 business users. Utilizing cloud and mobile internet technology, Huisuanzhang focuses on delivering standardized and refined financial services, enhancing user experience, and addressing the specific needs of SMEs throughout their life cycle. The platform aims to provide affordable and efficient financial solutions, continuously evolving to meet the demands of its clientele in a competitive market.
Sinoiov
Series B in 2019
Beijing Sinoiov Information Technology Co., Ltd. is a data technology company focused on transforming the road freight industry through logistics technology and service platforms. By leveraging artificial intelligence and big data analysis, Sinoiov aims to help logistics customers achieve digital and intelligent transformation, ultimately reducing costs and boosting efficiency. The company has developed a comprehensive freight monitoring platform that integrates GPS tracking, intelligent dispatching systems, and cloud computing, providing vital information for optimizing freight delivery operations. With a strong presence in China, including national vehicle networking industrial bases in Beijing and Chongqing and over 40 provincial branches, Sinoiov has accumulated extensive experience in commercial vehicle networking operation management and services.
DeepWise
Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
eCheng
Series C in 2019
ECheng (e成) is a B2B SaaS platform that provides HR matching and resume screening for enterprises. Using machine learning, data mining, and NLP (natural language processing), the company categorizes resumes that best fit the job requirements of the client company. The company was launched in 2013 by industry veterans from Baidu, IBM, and Microsoft, serving multinational conglomerates as well as small and medium-sized companies.
Zhihu
Series E in 2018
Zhihu is a prominent Chinese social question-and-answer platform that allows users to seek information by soliciting opinions and insights from individuals rather than relying solely on traditional forum responses. Established to foster a community-driven exchange of knowledge, Zhihu has grown significantly, with a registered user base exceeding 300,000 by early 2012. The company operates primarily within the online content community space, monetizing its services through a combination of paid memberships, advertising, content-commerce solutions, and vocational training offerings. All of its revenue is generated from within China, reflecting its focus on the domestic market and its commitment to providing users with a rich and engaging platform for knowledge sharing.
Meican
Series D in 2018
Meican.com is an online platform that specializes in food ordering and delivery services, catering to both individual and corporate clients. Founded in January 2011, the platform allows users to browse detailed take-out menus from over 30,000 partner restaurants in major cities such as Beijing, Shanghai, Guangzhou, and Shenzhen. Meican.com offers personalized meal selection, making it easy for users to choose their preferred dishes. Additionally, it provides enterprise solutions for efficient meal ordering, addressing challenges related to food classification and billing, thereby allowing businesses to focus on their core operations. Meican.com combines a wealth of experience in product research and development with a professional operational team, enhancing the overall food ordering experience for its users.
Carzone
Private Equity Round in 2018
Jiangsu Kangzhong Shiye Investment operates a retail chain, Carzone, that deals in and retails automotive post-market parts. The company was founded in 1995 and is based in Nanjing, China.
MEGVII
Series C in 2017
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.
DoBe Group
Series B in 2017
DoBe Group, established in Shanghai, China in 2006, specializes in developing and operating real estate properties tailored for cultural and creative industries. The company serves as a professional operator of creative office parks, offering comfortable workspaces alongside comprehensive services to facilitate the growth of cultural and creative enterprises. Additionally, DoBe Group provides enterprise management services, brand promotion services, and financial consulting services to support its tenants' development.
Kangfu Zhijia
Series D in 2016
Kangfu Zhijia is an omni-channel service provider of household medical equipment.
QuantGroup
Series C in 2016
Founded in 2014, QuantGroup is a data-driven financial services platform dedicated to enhancing traditional industries through advanced technology. The company specializes in providing scenario-based digital empowerment services that leverage artificial intelligence to integrate various aspects of business operations, including technology, traffic, and goods and services. With a commitment to independent research and development, QuantGroup offers tailored marketing solutions and financial technology integration services aimed at both consumers and financial institutions. Its mission centers on utilizing data to facilitate convenient and efficient services, ultimately striving to transform how businesses operate in the digital landscape.
Orbiepharm
Series C in 2016
Orbiepharm is a pharmaceutical manufacturing company specializing in animal health, particularly within the veterinary industry. The company develops a range of products, including solid preparations, ointments, insecticides, inhalational anesthetics, and oral solvents, targeting various health issues in pets. Their therapeutic offerings address common, medical, chronic, and geriatric diseases. Orbiepharm stands out as a unique enterprise in China, as it integrates research and development, production, sales, and terminal hospital services, thereby enhancing the efficiency of diagnosis and treatment for animals.
Zhongguo Qiye Bao
Angel Round in 2010
Zhongguo Qiye Bao is a newspaper publishing company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.